Af de 3 patienter med signifikant pulmonal påvirkning ved screening/ baseline (procenten for ” predicted forced vital capacity ” (FVC) i siddende stilling varierede fra 58 – 67%), udviste 2 klinisk betydelige forbedringer i FVC (+11, 5% og +16, 0%) i siddende stilling ved uge 26.
Of the 3 patients with significant pulmonary involvement at screening/ baseline (percentage predicted forced vital capacity in the sitting position ranging from 58-67%), two demonstrated clinically meaningful improvements in FVC (+11.5% and +16.0%) in the sitting position by Week 26.